25dkou005 10.3205/25dkou005 urn:nbn:de:0183-25dkou0051 Meeting Abstract Qiao Qiao Yu Y

Department of Orthopaedics and Sports Orthopaedics, TUM University Hospital, Technical University of Munich, Munich, Deutschland

author Eisfeld Eisfeld Carolin C

Department of Orthopaedics and Sports Orthopaedics, TUM University Hospital, Technical University of Munich, Munich, Deutschland

author von Eisenhart-Rothe von Eisenhart-Rothe Rüdiger R

Department of Orthopaedics and Sports Orthopaedics, TUM University Hospital, Technical University of Munich, Munich, Deutschland

author Hinterwimmer Hinterwimmer Florian F

Department of Orthopaedics and Sports Orthopaedics, TUM University Hospital, Technical University of Munich, Munich, Deutschland Institute for AI and Informatics in Medicine, TUM University Hospital, Technical University of Munich, Munich, Deutschland

author German Medical Science GMS Publishing House

Düsseldorf

610 20251031 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). M0634 005 Deutsche Gesellschaft für Orthopädie und Unfallchirurgie Deutsche Gesellschaft für Orthopädie und Orthopädische Chirurgie Deutsche Gesellschaft für Unfallchirurgie Berufsverband für Orthopädie und Unfallchirurgie Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2025) Poster | Digitalisierung Berlin 20251028 20251031 AB11-4146 TextObjectives and questions: Artificial intelligence (AI) techniques, particularly classical machine learning (ML) and deep learning (DL), have been increasingly applied to bone tumor research. These methods hold great promise to become a support tool for improving diagnostic accuracy, predicting survival, assessing treatment response, and assisting in tumor segmentation. Therefore, our study aims to summarize and analyze the research status and limitations of AI in the field of bone tumors in the last 5 years as well as analyze the potential future research directions.Material and methods: This systematic review follows to the PRISMA guidelines and conducted a comprehensive search of four major databases (PubMed, Web of Science, Scopus, and Cochrane Library) to identify studies published between January 2019 and October 2024 on the application of AI in bone tumors. Relevant original articles were identified based on predefined inclusion and exclusion criteria, and research data such as basic information, algorithms, models, performance metrics, and clinical tasks, were systematically extracted and analyzed.Results: The review included 57 studies involving 43,867 cases, of which 48.91% were malignant bone tumors. DL was used in 77.78% of the studies and classical ML in 20.63%. Diagnostic tasks dominated the research focus (82.46%), followed by survival prediction (8.47%) and treatment response evaluation (8.77%). Performance metrics showed that DL had higher weighted accuracy (0.87), weighted AUC (0.89), weighted sensitivity (0.84), and weighted specificity (0.89) compared to classical ML, whereas classical ML exhibited consistent precision (0.89). Some challenges were also pointed out, such as classical ML’s dependence on structured small sample data. Future trends suggest that, with the maturation of AI technologies, diagnostic applications will progressively shift toward survival prediction.Discussion and conclusions: AI has demonstrated high performance and potential in bone tumor research, especially in imaging-based tasks. Future research should focus on the development of Machine Learning/Deep Learning fusion algorithms to improve generalization performance, accuracy and the ability to adapt to complex data scenarios, as well as the development of tailored AI models for small data sets, which are crucial for improving the clinical impact of AI in bone tumor management. At the same time, fostering interdisciplinary and multicenter collaborations between computer scientists and clinicians, improving data-sharing frameworks, and addressing ethical and privacy concerns will be essential to fully harness the significant potential of AI in bone tumor research and clinical applications.Figure 1 0

1 1 Figure 1

1 0 0